Acquired Brain Injury, Cognitive Impairment, Speech Dysfunction
Conditions
Brief summary
The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders. The main question it aims to answer is: " Is it feasible to use a web-based platform for delivering rehabilitation treatment in a large acute National Health Care Organisation" Participants will undergo therapy sessions prescribed by therapists on a web-based platform instead of the conventional paper-based therapy sessions for their cognitive and speech rehabilitation needs.
Detailed description
The population group will be adult patients admitted to critical care unit and stroke unit and diagnosed to have speech and cognitive impairment. The intervention is to provide therapy prescribed by therapist through Cognishine, a web-based platform instead of paper-based therapy session. The primary objective is to assess feasibility of using the Cognishine web-based platform in a large NHS Trust in acute care setting measured by number of completed therapy sessions, per patient days.
Interventions
BEHAVIORALa Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders
The Cognishine platform is a digital (web-based) general health and wellness monitoring platform. It is designed to support health care professionals specialised in rehabilitation of patients with neurological disorders, through a wide range of multi-media based generalised activities across speech, language, social-emotional, and cognition.
Sponsors
Liverpool University Hospitals NHS Foundation Trust
Israel Innovation Authority
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with cognitive impairment and/or speech impairment being treated at the LUHFT Intensive Care Units and the Stroke wards * Need for Cognitive and/or speech and Language rehabilitation
Exclusion criteria
* Inability to obtain consent * Refusal to take part in the study * Failure to engage with the Cognishine platform * Inability to operate a mobile device/ tablet with support * Unavailability of study therapist to provide training of patients * Unstable medical condition
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To assess the feasibility of using the Cognishine web-based platform in a large NHS Trust in acute care setting. | From recruitment until discharge from rehabilitation therapy or discharge from hospital, which ever comes first. Time frames will vary dependent on patient recovery .The anticipated time frame is 1 to 6 months. Maximum follow up is 12 months. | Total number of completed sessions per patient on the cognishine platform |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To assess staff and patient experience of using the Cognishine platform during therapy sessions. | Patients will be asked to complete this on discharge from hospital. Therapists will be asked to complete the questionnaire one month after starting the study (in the middle of recruitment) | Patients \& therapists will be asked to complete the Mobile Health App Usability Questionnaire (MAUQ)for Interactive Mobile Health Apps used by patients. The questionnaire is designed and validated to evaluate the usability of interactive health apps from the users perspective. The MAUQ questionnaire comprises of 21 questions which cover 3 main usability domains. 1. Ease of use-Navigation, learnability and clarity. 2. Interface and satisfaction-Visual appeal, confidence and overall satisfaction. 3. Usefulness-Perceived value and effectiveness in helping users achieve their health goals. Scoring is via a 7 point Likert scale (1 - strongly disagree, 2 - disagree, 3 - somewhat disagree, 4 - neither agree nor disagree, 5 - somewhat agree, 6 -agree, 7 - strongly agree.),with higher scores indicating greater usability and satisfaction. |
| To generate qualitative data about how to improve the end user experience for therapist to target barriers to implementation | 12 month into the study. | Focus groups composed of therapists who have used the platform will be asked to provide end user information about using the system. This qualitative data will be used to improve the platform. |
| To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform. | As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 months. | The Montreal Cognitive Assessment (MoCA) is a standard clinical measurement tool. The tool comprises assessment of visuospatial/executive functions ,naming, memory, attention, language ,abstraction and orientation. The scoring range is 0-30,with higher scores indicating better cognition, scores of \<26 indicating possible cognitive impairment. Scores will be collected from clinical notes at initial assessment and at discharge from rehabilitation therapy. |
Countries
United Kingdom
Contacts
CONTACTVinoth Sankar
STUDY_CHAIRMatthew Noonan
Liverpool University Hospitals NHS Foundation Trust
Outcome results
None listed